Please use this identifier to cite or link to this item:
|Title:||Gastric acid control, amylase activity and proton pump inhibitors|
Azzopardi, Lilian M.
Proton pump inhibitors -- Therapeutic use
Gastric juice -- Analysis
Stomach -- Diseases -- Diagnosis
|Publisher:||University of Malta. Department of Pharmacy|
|Citation:||Galea, C., Azzopardi, L. M., Serracino-Inglott, A., & LaFerla, G. (2013, August). Gastric acid control, amylase activity and proton pump inhibitors. Poster session presented at the International Pharmaceutical Federation (FIP) World Congress, Dublin, Ireland.|
|Abstract:||A poster presentation regarding gastric acid control, amylase activity and proton pump inhibitors. Introduction: Proton pump inhibitors increase gastric pH to ensure healing of duodenal and gastric ulcers. However, this increased pH is also the optimal pH for salivary (S-AM) and pancreatic amylase (P-AM) activity in gastric juice. Could a high amylase level in gastric juice explain dyspepsia in patients who fail to respond to standard PPI treatment?. Aims: • To quantify total (AMYL) and pancreatic active amylase present in gastric juice samples. • To correlate any relevant patient and drug history with the gastric amylase activity.|
|Appears in Collections:||Scholarly Works - FacM&SPha|
Files in This Item:
|Gastric_acid_control_amylase_activity_and_proton_pump_inhibitors_2013.pdf||822.25 kB||Adobe PDF||View/Open|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.